Table 1. Demographic and Baseline Clinical Characteristics of the Study Patientsa.
| Characteristics | Propranolol Group (n = 17) |
Steroid Group (n = 17) |
P Value |
|---|---|---|---|
| Patients | |||
| Age, mo | 3.6 (0.3-8.2) | 3.0 (0.8-8.0) | .37b |
| Boys, No. (%) | 7 (41) | 8 (47) | .73c |
| Weight, kg | 6.45 (1.73) | 6.02 (1.68) | .48b |
| Height, cm | 61.75 (6.05) | 60.51 (5.96) | .55b |
| Blood pressure, mm Hg | |||
| Systolic | 88 (80-112) | 91 (76-108) | .40d |
| Diastolic | 49.82 (10.76) | 50.59(10.69) | .84b |
| Heart rate, beats/min | 128 (109-167) | 140 (118-160) | .11d |
| Respiration rate, breaths/min | 36 (30-40) | 36 (32-44) | .86d |
| Body temperature, °C | 36.89 (0.41) | 36.93 (0.38) | .80b |
| Hemangiomas | |||
| Location, No. (%) of patients | |||
| Scalp | 1 (6) | 2 (12)e | >.99f |
| Face | 10 (59)g | 13 (76) | .46f |
| Chest | 2 (12)g | 0 | .48f |
| Abdomen | 1 (6) | 0 | >.99f |
| Back | 1 (6) | 0 | >.99f |
| Upper extremity | 3 (18) | 2 (12) | >.99f |
| Lower extremity | 0 | 1 (6)e | >.99f |
| Size | |||
| Volume, mm3 by MRI | 14 125.35 (18 246.77) | 9349.54 (16 015.69) | .33d |
| Surface area, mm2 | 1318.06 (1833.07) | 1093.51 (1316.68) | >.99d |
| Height, mm | 4.26 (2.22) | 3.71 (2.49) | .50b |
| Color, No. (%) of patients | |||
| Red | 11 (65) | 14 (82) | .48f |
| Purple | 2 (12) | 1 (6) | NR |
| Blue | 1 (6) | 0 | NR |
| Gray | 0 | 1 (6) | NR |
| Apricot | 0 | 0 | NR |
| Other | 3 (18) | 1 (6) | NR |
| Purple/blue | 1 (6) | 0 | NR |
| Red/blue | 0 | 1 (6) | NR |
| Red to purple | 1 (6) | 0 | NR |
| Reddish purple | 1 (6) | 0 | NR |
| Ulcer, No. (%) of patients | |||
| Yes | 1 (6) | 1 (6) | >.99f |
| Reepithelization, No. (%) of patients | |||
| Yes | 2 (12) | 0 | .48f |
Abbreviations: MRI, magnetic resonance imaging, NR, not reported.
a
Unless otherwise indicated, data are reported as mean (range) or mean (SD).
b
Independent t test.
c
χ2 Test.
d
Wilcoxon rank-sum test.
e
Two lesions in 1 patient in the propranolol group (both the scalp and lower extremity).
f
Fisher exact test.
g
Two lesions in 1 patient in the steroid group (both the face and chest).